215 related articles for article (PubMed ID: 37194791)
1. Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: a pilot study.
Gholami S; Chamorro-Petronacci C; Pérez-Sayáns M; Suárez Peñaranda J; Longatto-Filho A; Baltazar F; Afonso J
J Appl Oral Sci; 2023; 31():e20220461. PubMed ID: 37194791
[TBL] [Abstract][Full Text] [Related]
2. Clinical relevance of serum lipids in the carcinogenesis of oral squamous cell carcinoma.
Qian L; Qian B; Xu J; Yang J; Wu G; Zhao Y; Liu Q; Yuan Z; Fan Y; Li H
BMC Oral Health; 2023 Apr; 23(1):200. PubMed ID: 37013557
[TBL] [Abstract][Full Text] [Related]
3. Comparison of PD-L1 Expression in Oral Squamous Cell Carcinoma and Premalignant Lesions of Oral Cavity.
Saeed S; Rauf F; Iqbal F; Khan AS; Khan AH; Alamgeer R
Asian Pac J Cancer Prev; 2022 Dec; 23(12):4039-4045. PubMed ID: 36579984
[TBL] [Abstract][Full Text] [Related]
4. TIMELESS promotes reprogramming of glucose metabolism in oral squamous cell carcinoma.
Chen Y; Han Z; Zhang L; Gao C; Wei J; Yang X; Han Y; Li Y; Zhang C; Wei Y; Dong J; Xun W; Sun W; Zhang T; Zhang H; Chen J; Yuan P
J Transl Med; 2024 Jan; 22(1):21. PubMed ID: 38178094
[TBL] [Abstract][Full Text] [Related]
5. Oral Squamous Cell Carcinoma Associated with Precursor Lesions.
McCord C; Kiss A; Magalhaes MA; Leong IT; Jorden T; Bradley G
Cancer Prev Res (Phila); 2021 Sep; 14(9):873-884. PubMed ID: 34193432
[TBL] [Abstract][Full Text] [Related]
6. Clinically relevant HIF-1α-dependent metabolic reprogramming in oropharyngeal squamous cell carcinomas includes coordinated activation of CAIX and the miR-210/ISCU signaling axis, but not MCT1 and MCT4 upregulation.
Sáenz-de-Santa-María I; Bernardo-Castiñeira C; Secades P; Bernaldo-de-Quirós S; Rodrigo JP; Astudillo A; Chiara MD
Oncotarget; 2017 Feb; 8(8):13730-13746. PubMed ID: 28099149
[TBL] [Abstract][Full Text] [Related]
7. Risk prediction for malignant conversion of oral epithelial dysplasia by hypoxia related protein expression.
Zhang X; Han S; Han HY; Ryu MH; Kim KY; Choi EJ; Cha IH; Kim J
Pathology; 2013 Aug; 45(5):478-83. PubMed ID: 23811806
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Diagnostic Significance of Salivary miRNA-184 and miRNA-21 in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.
Garg A; Urs AB; Koner BC; Augustine J; Guru SA
Head Neck Pathol; 2023 Dec; 17(4):961-968. PubMed ID: 38015343
[TBL] [Abstract][Full Text] [Related]
9. Revisiting the evidence of photodynamic therapy for oral potentially malignant disorders and oral squamous cell carcinoma: An overview of systematic reviews.
Schuch LF; Schmidt TR; Kirschnick LB; de Arruda JAA; Campagnol D; Martins MAT; Santos-Silva AR; Lopes MA; Vargas PA; Bagnato VS; Kurachi C; Guerra ENS; Martins MD
Photodiagnosis Photodyn Ther; 2023 Jun; 42():103531. PubMed ID: 36963644
[TBL] [Abstract][Full Text] [Related]
10. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Salivary Electrolytes Profile in Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma.
Saavedra JA; Novo DR; Mesko MF; Uchoa Vasconcellos AC; Duarte Da Silva K; Rojas Zuñiga G; Ramires RF; Tarquinio SBC
Asian Pac J Cancer Prev; 2022 Mar; 23(3):1031-1039. PubMed ID: 35345377
[TBL] [Abstract][Full Text] [Related]
12. High-Risk Human Papillomavirus in Patients with Oral Carcinoma and Oral Potentially Malignant Disorders in Serbia-A Pilot Study.
Petrović A; Čanković M; Avramov M; Popović ŽD; Janković S; Mojsilović S
Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893561
[No Abstract] [Full Text] [Related]
13. MiRNAs as non-invasive biomarkers in the serum of Oral Squamous Cell Carcinoma (OSCC) and Oral Potentially Malignant Disorder (OPMD) patients.
Mazumder S; Basu B; Ray JG; Chatterjee R
Arch Oral Biol; 2023 Mar; 147():105627. PubMed ID: 36657275
[TBL] [Abstract][Full Text] [Related]
14. PAI-1, CAIX, and VEGFA expressions as prognosis markers in oral squamous cell carcinoma.
Peterle GT; Maia LL; Trivilin LO; de Oliveira MM; Dos Santos JG; Mendes SO; Stur E; Agostini LP; Rocha LA; Moysés RA; Cury PM; Nunes FD; Louro ID; Dos Santos M; da Silva AMÁ
J Oral Pathol Med; 2018 Jul; 47(6):566-574. PubMed ID: 29693741
[TBL] [Abstract][Full Text] [Related]
15. GLUT1 and GLUT3 as potential prognostic markers for Oral Squamous Cell Carcinoma.
Ayala FR; Rocha RM; Carvalho KC; Carvalho AL; da Cunha IW; Lourenço SV; Soares FA
Molecules; 2010 Apr; 15(4):2374-87. PubMed ID: 20428049
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of Candida species diversity among patients with oral squamous cell carcinoma and oral potentially malignant disorders.
Sankari SL; Mahalakshmi K; Kumar VN
BMC Res Notes; 2020 Oct; 13(1):488. PubMed ID: 33081839
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the association of OCT3/4 with GLUT1 and CD105 in oral squamous cell carcinoma using dual immunohistochemistry.
Derakhshan S; Mahdavi N; Kardouni Khoozestani N; Nasr Esfahani B; Heidarian F; Rahrotaban S; Abdolrahmani A
BMC Oral Health; 2022 Jul; 22(1):300. PubMed ID: 35854304
[TBL] [Abstract][Full Text] [Related]
18. Programmable bio-nanochip-based cytologic testing of oral potentially malignant disorders in Fanconi anemia.
Floriano PN; Abram T; Taylor L; Le C; Talavera H; Nguyen M; Raja R; Gillenwater A; McDevitt J; Vigneswaran N
Oral Dis; 2015 Jul; 21(5):593-601. PubMed ID: 25662766
[TBL] [Abstract][Full Text] [Related]
19. Regular clinical follow-up of oral potentially malignant disorders results in improved survival for patients who develop oral cancer.
Jäwert F; Nyman J; Olsson E; Adok C; Helmersson M; Öhman J
Oral Oncol; 2021 Oct; 121():105469. PubMed ID: 34371451
[TBL] [Abstract][Full Text] [Related]
20. Single-Cell RNA Sequencing Analysis for Oncogenic Mechanisms Underlying Oral Squamous Cell Carcinoma Carcinogenesis with
Hsieh YP; Wu YH; Cheng SM; Lin FK; Hwang DY; Jiang SS; Chen KC; Chen MY; Chiang WF; Liu KJ; Huynh NC; Huang WT; Huang TT
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
